Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioCryst Hits Trifecta For Flu, Ebola, and Hereditary Angioedema
BioCryst Hits Trifecta For Flu, Ebola, and Hereditary Angioedema
BioCryst Hits Trifecta For Flu, Ebola, and Hereditary Angioedema
Submitted by
admin
on December 26, 2014 - 10:22pm
Source:
Forbes
News Tags:
Biocryst
Flu
ebola virus
hereditary angiodema
Rapivab
BCX4430
BCX4161
Headline:
BioCryst Hits Trifecta For Flu, Ebola, and Hereditary Angioedema
Do Not Allow Advertisers to Use My Personal information
